Compare IRMD & NBXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IRMD | NBXG |
|---|---|---|
| Founded | 1992 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2014 | 2021 |
| Metric | IRMD | NBXG |
|---|---|---|
| Price | $81.28 | $13.43 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $118.00 | N/A |
| AVG Volume (30 Days) | 91.1K | ★ 234.8K |
| Earning Date | 10-30-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.97% | N/A |
| EPS Growth | ★ 16.67 | N/A |
| EPS | ★ 1.37 | N/A |
| Revenue | ★ $83,814,000.00 | N/A |
| Revenue This Year | $9.69 | N/A |
| Revenue Next Year | $11.28 | N/A |
| P/E Ratio | $60.41 | ★ N/A |
| Revenue Growth | ★ 14.43 | N/A |
| 52 Week Low | $76.35 | $12.32 |
| 52 Week High | $107.90 | $17.43 |
| Indicator | IRMD | NBXG |
|---|---|---|
| Relative Strength Index (RSI) | 39.26 | 35.61 |
| Support Level | $76.65 | $13.19 |
| Resistance Level | $89.25 | $14.00 |
| Average True Range (ATR) | 2.88 | 0.41 |
| MACD | -0.33 | -0.04 |
| Stochastic Oscillator | 27.73 | 11.15 |
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.
Neuberger Berman Next Generation Connectivity Fund Inc. is a non-diversified, closed-end management investment company. The fund's investment objectives are to provide capital appreciation and income. Under normal market conditions, the Fund will invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. companies, in any market capitalization range, that is relevant to the theme of investing in NextGen Companies.